Antares Pharma, Inc. (ATRS)

Financing Cash Flow

-$21.70M

TTM · Period ending: · USD

ATRS logo

ATRS Financing Cash Flow

Latest reported-$21.70M
ATRS TTM Cash from Financing (-$44.16K → -$21.70M)
High-resolution chart · PNG

ATRS financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-21,695,000
-19,990,000
-17,637,000
-12,555,000
2,495,000
447,000
3,823,000
2,892,000
17,866,000
25,919,000
29,464,000
28,955,000
14,874,000
7,045,000
-31,902
80,227
25,790,017
26,273,000
26,185,388
26,430,330
432,920
17,461
-9,225
-317,465
42,770,508
42,793,707
42,959,469
44,736,453
1,817,616
2,950,705
4,324,370
2,942,511
3,345,581
2,222,509
55,958,160
60,181,834
64,323,401
64,878,685
9,620,343
5,506,491
22,542,036
27,067,863
27,448,266
27,570,142
7,130,453
2,463,419
2,033,706
8,506,551
6,640,122
5,606,808
5,200,074
-2,206,924
-1,492,206
-808,641
1,729,482
16,931,695
18,976,926
23,851,897
21,947,282
7,336,568
5,288,250
11,117,141
11,500,141
11,500,141
11,324,930
619,700
605,049
598,334
546,783
15,140,603
14,528,197
18,458,971
20,001,589
5,595,813
6,379,239
4,017,745
3,841,733
4,571,212
-3,856,373
-5,409,462
-6,679,478
3,424,959
13,194,123
14,127,044
15,579,972
4,994,128
3,232,249
2,289,852
841,885
344,069
938,560
938,560
938,560
938,560
-44,164
-44,164
-44,164
-44,164
11,045,406
10,545,406
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.